Over time, one can envision conducting biomonitoring of indicators of biologic susceptibility to certain industrial or pharmaceutical agents.
Physical and cognitive functioning are both indicators of biologic aging the progressive generalized impairment of functioning that occurs when people grow older.
A biomarker is a characteristic that is measured as an indicator of normal biologic processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions.
Biomarker (biological marker) is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic response to a therapeutic intervention.
The biomarker should be a measurable indicator of normal biologic processes, pathogenic processes, or therapeutic responses, for the risk assessment, early diagnosis, and predicting and monitoring responses to therapies and toxicities [4, 5].
A biomarker is defined as a characteristic that is measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.
The official National Institutes of Health definition of a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic response to a therapeutic intervention" [ 67].
A biomarker is defined as a characteristic that may be objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention [ 1].
A biomarker, according to Illei and colleagues, is 'a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention'.
